The benzopyranopyrrole S33084 displayed pronounced affinity (pKi 5 9.6) for cloned human hD3-receptors, and.100-fold lower affinity for hD2 and all other receptors (.30) examined. S33084 concentration dependently, potently, and competitively (pA2 5 9.7) antagonized dopamine (DA)-induced [ 35S]guanosine-59- O-(3-thio)triphosphate (GTPgS) binding at hD3-receptors. It also concentration dependently abolished stimulation by DA of hD3-receptor-coupled mitogen-activated protein kinase. Ad-ministered alone, S33084 did not modify dialysate levels of DA in the frontal cortex, nucleus accumbens, or striatum of freely moving rats, nor the firing rate of ventrotegmental dopaminer-gic cell bodies. Furthermore, it had minimal effect on DA turn-over in me...
The dopamine D-3 receptor is predominantly expressed in limbic regions of the brain, such as the nuc...
Dopamine D3 receptors have been pharmacologically engaged in humans since the development of the fir...
The affinity and intrinsic activity of dopamine receptor agonists were determined at the human dopam...
The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyr...
The present study determined the biochemical and pharmacological effects of PD 128907 [R-(+)-trans-3...
PD 128907 [4a R, 10 b R-(+)-trans-3, 4, 4a, 10 b-tetrahydro-4-n-propyl2 H,5H-[1]benzop-yrano[4,3-b] ...
To date, the lack of highly selective antagonists at the dopamine D 3 receptor has hampered clarific...
The synthesis, pharmacological evaluation, and structure-activity relationships (SARs) of a series o...
F17464 (N-(3-{4-[4-(8-Oxo-8H-[1,3]-dioxolo-[4,5-g]-chromen-7-yl)-butyl]-piperazin-1-yl}-phenyl)-meth...
ABSTRACT: We report a class of potent and selective dopamine D3 receptor antagonists based upon tran...
Despite evidence linking dopamine D3 receptors to the etiology of Parkinson’s disease and L-DOPAindu...
S18327 displayed modest affinity for human (h)D2 and hD3 receptors and high affinity for hD4 recepto...
By examining the effect of dopamine (DA) D-3 receptor stimulation on locomotor activity and extracel...
Dopamine D2-like receptors play an important role in the phar-macotherapy of psychotic disorders. Mo...
D3 receptors represent a major focus of current drug design and development of therapeutics for dopa...
The dopamine D-3 receptor is predominantly expressed in limbic regions of the brain, such as the nuc...
Dopamine D3 receptors have been pharmacologically engaged in humans since the development of the fir...
The affinity and intrinsic activity of dopamine receptor agonists were determined at the human dopam...
The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyr...
The present study determined the biochemical and pharmacological effects of PD 128907 [R-(+)-trans-3...
PD 128907 [4a R, 10 b R-(+)-trans-3, 4, 4a, 10 b-tetrahydro-4-n-propyl2 H,5H-[1]benzop-yrano[4,3-b] ...
To date, the lack of highly selective antagonists at the dopamine D 3 receptor has hampered clarific...
The synthesis, pharmacological evaluation, and structure-activity relationships (SARs) of a series o...
F17464 (N-(3-{4-[4-(8-Oxo-8H-[1,3]-dioxolo-[4,5-g]-chromen-7-yl)-butyl]-piperazin-1-yl}-phenyl)-meth...
ABSTRACT: We report a class of potent and selective dopamine D3 receptor antagonists based upon tran...
Despite evidence linking dopamine D3 receptors to the etiology of Parkinson’s disease and L-DOPAindu...
S18327 displayed modest affinity for human (h)D2 and hD3 receptors and high affinity for hD4 recepto...
By examining the effect of dopamine (DA) D-3 receptor stimulation on locomotor activity and extracel...
Dopamine D2-like receptors play an important role in the phar-macotherapy of psychotic disorders. Mo...
D3 receptors represent a major focus of current drug design and development of therapeutics for dopa...
The dopamine D-3 receptor is predominantly expressed in limbic regions of the brain, such as the nuc...
Dopamine D3 receptors have been pharmacologically engaged in humans since the development of the fir...
The affinity and intrinsic activity of dopamine receptor agonists were determined at the human dopam...